Browsing by Author Clark, IA

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 3 to 13 of 13< previous 
Issue DateTitleAuthor(s)
27-Jan-2014Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's DiseaseMorris, GP; Clark, IA; Vissel, B
21-Mar-2014Inflammation-sleep interface in brain disease: TNF, insulin, orexinClark, IA; Vissel, B
19-Apr-2018The inflammatory nature of post-surgical delirium predicts benefit of agents with anti-TNF effects, such as dexmedetomidineClark, IA; Vissel, B
1-Jul-2017The meteorology of cytokine storms, and the clinical usefulness of this knowledgeClark, IA; Vissel, B
1-Oct-2013Microglia: A new frontier for synaptic plasticity, learning and memory, and neurodegenerative disease researchMorris, GP; Clark, IA; Zinn, R; Vissel, B
3-Jun-2019Neurodegenerative disease treatments by direct TNF reduction, SB623 cells, maraviroc and irisin and MCC950, from an inflammatory perspective–a CommentaryClark, IA; Vissel, B
1-Apr-2013Neuroinflammation and Neuronal Loss Precede Aβ Plaque Deposition in the hAPP-J20 Mouse Model of Alzheimer's DiseaseWright, AL; Zinn, R; Hohensinn, B; Konen, LM; Beynon, SB; Tan, RP; Clark, IA; Abdipranoto, A; Vissel, B
1-Jan-2015A Neurologist's Guide to TNF Biology and to the Principles behind the Therapeutic Removal of Excess TNF in DiseaseClark, IA; Vissel, B
1-Oct-2018Therapeutic implications of how TNF links apolipoprotein E, phosphorylated tau, α-synuclein, amyloid-β and insulin resistance in neurodegenerative diseasesClark, IA; Vissel, B
1-Jan-2011TNF and leptin tell essentially the same story in alzheimer's diseaseClark, IA; Alleva, LM; Vissel, B
1-Jan-2013Treatment implications of the altered cytokine-insulin axis in neurodegenerative diseaseClark, IA; Vissel, B